Concepedia

Marc Laisney

ML

Statistics

Publications

4

Citations

183

H-Index

4

Active since

2013

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Marc Laisney is an author at Novartis (Switzerland) specializing in pharmacology, drug disposition, and pharmacokinetics.

Publications per year

2013–2021

4

Publications

4

Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake: <i>In Silico</i> and Clinical Evaluations

Tanay S. Samant, Shyeilla V. Dhuria, Yasong Lu et al. · Clinical Pharmacology & Therapeutics · 2017 · 81 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Physiologically Based Biopharmaceutics Modeling to Demonstrate Virtual Bioequivalence and Bioequivalence Safe-space for Ribociclib which has Permeation Rate-controlled Absorption

Marc Laisney, Tycho Heimbach, Martin Mueller‐Zsigmondy et al. · Journal of Pharmaceutical Sciences · 2021 · 53 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology

Kea Martin, Ursula Junker, Elaine Tritto et al. · Frontiers in Immunology · 2020 · 39 citations · Full text

Life Sciences, Immunology, Pathology +17

Comparison of the<i>in vitro</i>and<i>in vivo</i>metabolism of Cladribine (Leustatin, Movectro) in animals and human

Holger Scheible, Marc Laisney, Elmar Wimmer et al. · Xenobiotica · 2013 · 10 citations

Medicine, Pharmacokinetics, Pharmacology +8

1–4 of 4